Jump to content

Erinacine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Achagau (talk | contribs) at 21:05, 16 January 2024 (Remove text plagiarized from the introduction of doi.org/10.1080/21501201003735556). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Chemical structures of erinacines A-I

Erinacines are natural substances isolated from Hericium erinaceus. They belong to the group of cyathin diterpenoids (erinacines A-K, P, and Q) and are subjects of pharmacological research.

Erinacine A

Erinacine A, isolated from the cultured mycelia of Hericium erinaceus, the main representative of this compounds group, has an enhancing effect on nerve growth factor synthesis in vitro.[1] It also increases catecholamine in the central nervous system of rats.[citation needed]

Erinacine A has also been prepared by total synthesis.[2]

Erinacine E

Erinacine E is a kappa opioid receptor agonist.[3]

References

  1. ^ Hirokazu Kawagishi; Atsushi Shimada; Ryoko Shirai; Kenji Okamoto; Fumihiro Ojima; Hideki Sakamoto; Yukio Ishiguro; Shoei Furukawa (1994). "Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum". Tetrahedron Letters. 35 (10): 1569–1572. doi:10.1016/S0040-4039(00)76760-8.
  2. ^ Barry B. Snider; Nha Huu Vo; Steven V. O'Neil & Bruce M. Foxman (1996). "Synthesis of (±)-Allocyathin B2 and (+)-Erinacine A". J. Am. Chem. Soc. 118 (32): 7644–7645. doi:10.1021/ja9615379.
  3. ^ Saito T, Aoki F, Hirai H, et al. (November 1998). "Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum". The Journal of Antibiotics. 51 (11): 983–90. doi:10.7164/antibiotics.51.983. PMID 9918390.

Further reading